))
Episode: 17 - Pfizer’s AI Approach: A Business Strategy for a Digital World
Manage episode 362444156 series 3319353
Content provided by Bio-IT World. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Bio-IT World or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
At Pfizer, AI plays a key role in every step of the drug discovery process, Anastasia Christianson, Global Head of AI, ML, Analytics, and Data at Pfizer, tells Stan Gloss on the latest episode of the Trends from the Trenches podcast. Christianson lists the areas at Pfizer where AI is in play and for which she has AI/ML responsibility: research and discovery, clinical development, manufacturing supply chain, commercial, medical affairs, human resources, financial departments, and more. Pfizer doesn’t have a digital strategy, Christianson says, turning that buzzword on its head. “Instead, we have a business strategy for a digital world.”
Links from this episode:
Bio-IT World
BioTeam
Pfizer
Christianson’s Plenary Presentation at the Bio-IT World Conference & Expo
Trends from the Trenches boiler: Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.
36 episodes
Share
